LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Search

Essa Pharma Inc

Затворен

0.2

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.19

Максимум

0.2

Ключови измерители

By Trading Economics

Приходи

2.4M

-4M

EPS

-0.14

Дивидентна доходност

87.56

Марж на печалбата

-4,681.422

Служители

35

EBITDA

1.4M

-5M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

87.56%

3.12%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-73M

11M

Предишно отваряне

0.2

Предишно затваряне

0.2

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Essa Pharma Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.09.2025 г., 22:41 ч. UTC

Значими двигатели на пазара

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12.09.2025 г., 16:04 ч. UTC

Значими двигатели на пазара

Upexi Shares Climb on Solana Gains

14.09.2025 г., 23:48 ч. UTC

Пазарно говорене

Oil Futures Mixed Amid Divergent Signals -- Market Talk

14.09.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Edges Lower on Likely Technical Correction -- Market Talk

14.09.2025 г., 23:38 ч. UTC

Пазарно говорене

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

14.09.2025 г., 23:13 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

14.09.2025 г., 23:13 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

14.09.2025 г., 23:13 ч. UTC

Пазарно говорене

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

14.09.2025 г., 23:13 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.09.2025 г., 23:04 ч. UTC

Пазарно говорене

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

13.09.2025 г., 08:20 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

12.09.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

12.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.09.2025 г., 20:09 ч. UTC

Печалби

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12.09.2025 г., 19:23 ч. UTC

Пазарно говорене

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12.09.2025 г., 19:16 ч. UTC

Пазарно говорене

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12.09.2025 г., 19:03 ч. UTC

Пазарно говорене

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12.09.2025 г., 18:59 ч. UTC

Пазарно говорене

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12.09.2025 г., 18:38 ч. UTC

Пазарно говорене
Печалби

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12.09.2025 г., 18:33 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12.09.2025 г., 18:22 ч. UTC

Пазарно говорене

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12.09.2025 г., 16:56 ч. UTC

Пазарно говорене

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12.09.2025 г., 16:22 ч. UTC

Печалби

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.09.2025 г., 16:19 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12.09.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

12.09.2025 г., 16:11 ч. UTC

Печалби

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12.09.2025 г., 15:37 ч. UTC

Пазарно говорене

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12.09.2025 г., 15:22 ч. UTC

Пазарно говорене

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12.09.2025 г., 15:07 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Essa Pharma Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

1.7 / 1.72Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
help-icon Live chat